Aldesleukin Completed Phase 1 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00027807Biological Therapy in Treating Women With Stage IV Breast Cancer